Is a history of purging a contraindication to bupropion (Wellbutrin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, a history of purging (bulimia) is an absolute contraindication to bupropion (Wellbutrin).

Bupropion should NOT be used in patients with a current or prior diagnosis of bulimia or anorexia nervosa due to a significantly increased risk of seizures. This is an FDA-mandated contraindication, not merely a precaution 1.

Why This Contraindication Exists

The contraindication stems from historical clinical evidence showing a markedly elevated seizure incidence in bulimic patients:

  • Bupropion was temporarily withdrawn from the market in 1986 after clinical trials revealed an unacceptably high rate of grand mal seizures in patients with bulimia 2.

  • A multicenter controlled trial found 4 out of 55 bulimic patients (7.3%) experienced grand mal seizures while taking bupropion—a rate far exceeding that seen in other patient populations 3.

  • The drug was only reintroduced in 1989 after establishing that seizure risk was dose-dependent in non-bulimic populations, with a 2-year cumulative seizure risk of 0.48% at maximum recommended doses (≤450 mg/day) 2.

Clinical Implications

This contraindication applies regardless of:

  • Whether the bulimia is currently active or in remission (history alone is sufficient)
  • The formulation of bupropion (IR, SR, XL, or combination products like naltrexone/bupropion ER)
  • The intended use (depression, smoking cessation, weight loss, ADHD)

Multiple authoritative guidelines consistently reinforce this contraindication:

  • AACE/ACE Obesity Guidelines (2016): State that bupropion-containing weight-loss medications "should not be used in patients with bulimia" 2.
  • NCCN Smoking Cessation Guidelines (2016): List bulimia as a contraindication for bupropion 4.
  • ATS Adolescent Nicotine Guidelines (2025): Specify that bupropion is contraindicated in patients with current or prior bulimia or anorexia nervosa 5.
  • FDA Drug Label: Explicitly lists bulimia and anorexia nervosa as contraindications 1.

Alternative Medications

For patients with a history of purging who need treatment:

For depression/anxiety:

  • Consider SSRIs, SNRIs, or other antidepressants without seizure risk

For weight management:

  • Orlistat, liraglutide, lorcaserin, or phentermine/topiramate ER are appropriate alternatives 2
  • Notably, medications containing topiramate may actually help reduce binge eating disorder symptoms 2

For smoking cessation:

  • Varenicline or nicotine replacement therapy are safer options 4, 6

Critical Caveat

One case report documented severe bupropion XR abuse (3,000-4,500 mg/day) in a patient with bulimia who used it to control binge eating and suppress appetite, ultimately resulting in grand mal seizures 7. This underscores both the contraindication's validity and the need for careful screening before prescribing bupropion, as patients may not spontaneously disclose eating disorder histories.

Bottom line: Screen all patients for current or past eating disorders before prescribing bupropion. If any history of bulimia or anorexia nervosa exists, do not prescribe bupropion in any form.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.